Hypertensive Disease in Pregnancy Flashcards
1
Q
Chronic vs Gestational Hypertension
A
- Chronic if HTN before 20 weeksin absence of hydatiform mole or persistent HTN beyond 6 weeks postpartum
- Gestational can be divided into:
- HTN without proteinuria
- Proteinuria without HTN
- Proteinuric HTN (pre-eclapmsia)
2
Q
Definition of pre-eclampsia
A
- HTN develping after 20 weeks gestation with one or more of proteinuria, maternal organ dysfunction or fetal growth restriction
- Potential forms of organ dysfunction include
- Renal insufficiency (creatinine >90micromol/L)
- Liver involvement (elevated transaminases + abdominal pain)
- Neurological complications (eclampsia, altered mental status, blindness, stroke, hyperreflexia, headache)
- Haematological complications (thrombocytopenia, DIC, haemolysis)
3
Q
Definition of severe pre-eclampsia
A
- Pre-eclampsia with severe hypertnsion +/- symptoms +/- biochemical or haematological impairment
4
Q
Definition of clampsia
A
- Generalised tonic-clonic convulsions in women with pre-eclampsia if seizures cannot be attributed to other causes
5
Q
Pathophysiology
A
- Phase 1 - Abnormal Placentation
- Normal - trophoblast invasion of maternal spiral arteries cause the diameter to increase 5 fold, converting high resistance, low low to low resistance, high flow.
- Abnormal (pre-eclampsia) - inadequate trophoblast invasion, causing inadequate placental perfusion caused by maternal immune reaction of paternal antigens expressed by fetus
- Phase 2 - Endothelial Dysfunction
- Widespread endothelial damage and dysfunction
- Likely to be mediated by oxidative stress originating from the ischaemic placenta
- Endothelial damage promotes platelet adhesion and thrombosis, and disturbs normal vascular tone
- Exaggerated maternal systemic inflammatory response, with activation of leucocytes, platelets and the coagulation system
- Relative deficiency of prostacyclin (vasodilator) and increased thromboxane A2
6
Q
Risk factors
A
- First pregnancy
- Family history
- Extremes of maternal age
- Obesity
- Medical factors
- Pre-existing HTN
- Renal disease
- Diabetes
- Acquired or inherited thrombophilia
- CTD
- Obstetric factors
- Multiple pregnancy
- Previous pre-eclampsia
- Hydrops fetalis (immune and non-immune)
- Hydatiform mole
- Triploidy
- Inter-pregnancy interval >10 years
7
Q
Presentation
A
- Severe headache
- Severe RUQ/epigastric pain
- Sudden swelling of hands, face or feet
- Visual disturbance including blurring, flashing, scotoma
- Vomiting
- Restlessness or agitation
- HTN and proteinuria
- Hyperreflexia
- Serum creatinine raised
- Platelet count decreased
- Clonus
- Haemolytic anaemia
- Elevated liver enzymes
- Retinal haemorrhages and papilloedema
8
Q
Clinical assessment
A
- Full assessment to differentiate HTN disorders
- BP
- Urinalysis for proteinuria
- Blood tests (AST and transaminitis indicate hepatocellular damage)
- Consider HEELP (haemolysis, elevated liver enzymes and low platelets)
9
Q
Blood tests
A
- FBC
- Low platelets
- Low Hb
- Haemolysis on blood film
- Renal function
- Reduced urine output
- Increased urate
- Increased urea
- Increased creatinine
- Coagulation system
- Prolonged coagulations indices
- Hepatic system
- Elevated ALT
- Elevated AST
10
Q
Fetal assessment
A
- Symphysial fundal height
- US for fetal growth, liquor volume and umbilical artery doppler
- If there is fetal compromise - delivery
11
Q
Prevention
A
- Aspirin inhibits prostaglandin synthesis via COX
- Low dose aspirin should inhibit the vascular and prothrombotic effects of thromboxane A2 in women at risk of pre-eclampsia
12
Q
Management
A
- Control maternal BP
- Assess fluid balance (too much = renal pulmonary oedema, too little = renal failure)
- Prevent seizures (eclampsia) - use magnesium sulphate
- Consider delivery
- Maternal indications - gestation >37 weeks, failure to control HTN, deteriorating liver/renal function, progressive fall in platelets, neurological complications
- Fetal indications - abnormal fetal HR, deteriorating fetal condition
- Optimise postnatal care
13
Q
Drug treatment
A
- Methyldopa
- Central action
- Intial drowsiness
- Safe, slow onset, not suitable if Hx of depression
- Labetalol
- Alpha and beta antagonist
- Postural hypotension, tiredness
- Hydralazine
- Direct-acting vasodilator
- Hypotension
- Nifedipine
- Calcium-channel antagonist
- Flushing, headaches
- Watch for precipitous fall in BP when used with magnesium sulphate
14
Q
Complications
A
- Maternal
- Intracranial haremorrhage
- Placental abruption and DIC
- Eclampsia
- HELLP synfrome (haemolysis, elevated liver enzymes and low platelets)
- Renal failure
- Pulmonary oedema
- Acute respiratory arrest
- Fetal
- IUGR
- Oligohydramnios
- Hypoxia from placental insufficiency
- Placental abruption
- Premature delivery